Name (Synonyms) | Correlation |
---|
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
This study is a prospective randomized controlled, double blind clinical trial performed on laboratory confirmed COVID-19 infection admitted patients in the Shamir Medical Center. The trial will include 30 patients who will undergo either hyperbaric oxygen therapy (HBOT) or Normobaric oxygen therapy (NBOT), randomized on a 2:1 ratio, within 4 days in addition to the standard treatment including oxygen, drugs, steroids, bronchodilators, antibiotics and others. The evaluation procedure includes symptom monitoring, room air saturation, vital signs monitoring, pulmonary function and blood tests at baseline, one day and one week after the last session. In addition, one hour prior to and post session saturation and vitals will be monitored.
Description: PaO2/FiO2
Measure: Oxygenation index Time: one day after the last sessionDescription: Room air saturation
Measure: SpO2 Time: 6 hours after a sessionDescription: Room air saturation
Measure: SpO2 Time: one week after the last sessionDescription: COVID19 symptoms
Measure: Symptoms level Time: one week after the last sessionDescription: Radiologic
Measure: Chest Xray Time: one week after the last session